The global sleep disorders market is entering a transformative phase, as rising incidence rates, expanding diagnostic capabilities, and an influx of technology-driven therapeutic solutions reshape the industry. Sleep disorders—which include a range of conditions such as insomnia, sleep apnea, circadian rhythm disorders, and parasomnias—have become a global public health concern, impacting mental and physical health, work productivity, and healthcare systems.
Global Sleep Disorders Market size and share is currently valued at USD 25.03 billion in 2024 and is anticipated to generate an estimated revenue of USD 66.55 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 10.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
Market Overview
Sleep disorders affect over one-third of the global adult population, yet a large portion of sufferers remain undiagnosed or untreated. The consequences of poor sleep range from cognitive decline and depression to cardiovascular disease and impaired immune function.
The market comprises diagnostic tools, treatment devices, pharmaceuticals, and behavioral interventions. Technological integration—especially through telehealth platforms, wearable tech, and artificial intelligence—has dramatically changed the way sleep issues are assessed and treated.
Notably, non-pharmacological options like cognitive behavioral therapy (CBT) are gaining momentum, particularly among patients seeking alternatives to prescription sleep aids.
Market Segmentation
1. By Disorder Type
Insomnia
Sleep Apnea
Restless Leg Syndrome
Narcolepsy
Circadian Rhythm Disorders
Parasomnias
Insomnia remains the largest segment, driven by stress, screen overexposure, and sedentary lifestyles. The sleep apnea segment, supported by rising obesity rates and cardiovascular comorbidities, is expected to post the fastest growth due to demand for sleep apnea devices like CPAP machines.
2. By Treatment
Pharmacological (medications)
Non-pharmacological (CBT, lifestyle modifications)
Devices (CPAP, oral appliances, wearable monitors)
Surgical Interventions
Cognitive behavioral therapy is expected to witness accelerated growth owing to its effectiveness in treating insomnia without the side effects associated with medication.
3. By Diagnosis
Polysomnography
Home Sleep Testing
Actigraphy
Wearable Trackers
Mobile Applications
With an increasing push toward home care, wearable trackers and app-based diagnostics are emerging as scalable solutions.
4. By End-User
Sleep Clinics
Hospitals
Homecare Settings
Wellness Centers
Homecare settings are projected to grow rapidly due to the convenience and affordability of remote diagnosis and treatment.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/sleep-disorder-market
Country-Wise Market Trends
United States
The U.S. is the dominant market player, generating more than 35% of global revenue. The prevalence of obesity, a key risk factor for sleep apnea, and high awareness of insomnia treatment options drive market maturity. The American Academy of Sleep Medicine (AASM) continues to push for early diagnosis through public awareness campaigns and insurance inclusion for cognitive behavioral therapy and diagnostic testing.
The adoption of digital sleep monitoring wearables from companies like Fitbit and Apple has made sleep tracking more mainstream. The FDA’s approval of orexin receptor antagonists has also broadened treatment options for insomnia.
Germany
Germany leads Europe in sleep disorder research and device innovation. Increased investment in public health programs, alongside a growing elderly population, drives demand for advanced sleep apnea devices. Local manufacturers are expanding product portfolios that integrate AI-based data analytics to improve diagnosis accuracy.
Germany’s emphasis on environmental and occupational health has also spurred government support for early diagnosis of work-related sleep disturbances, including circadian rhythm disorders.
Japan
Japan has one of the highest rates of sleep deprivation globally, leading to rising incidence of both insomnia and circadian rhythm disorders. Government-backed initiatives such as the “Sleep Guidelines for Health Promotion” and partnerships between universities and tech firms have resulted in innovations in sleep tech wearables and diagnostics.
A cultural shift toward mental health and wellness is increasing the use of cognitive behavioral therapy, especially via digital platforms. Startups offering AI-based CBT-I (Cognitive Behavioral Therapy for Insomnia) are gaining significant traction.
India
India is a fast-emerging market with immense potential due to rising urbanization, increased healthcare spending, and growing awareness. However, underdiagnosis remains a significant barrier.
The prevalence of sleep apnea is increasing due to lifestyle-induced comorbidities like hypertension and diabetes. As a result, demand for affordable CPAP machines and mobile diagnostic solutions is rising, especially in metro cities.
India also has a growing market for online cognitive behavioral therapy, particularly among younger demographics who prefer app-based mental health support.
China
China’s sleep disorders market is witnessing steady growth driven by urban stress, pollution, and digital fatigue. The Chinese government has included sleep health in national healthcare planning, and wearable tech adoption is booming.
With one of the largest elderly populations in the world, demand for sleep apnea devices is set to skyrocket. China is also experiencing a rise in sleep research institutions and partnerships with global companies to import or co-develop innovative sleep solutions.
United Kingdom
The UK sleep disorders market is expanding due to NHS reforms that emphasize mental health and wellness. Public awareness campaigns and digital health solutions have made insomnia treatment more accessible.
The UK’s National Institute for Health and Care Excellence (NICE) has endorsed cognitive behavioral therapy as the first-line treatment for chronic insomnia, boosting its adoption across both private and public healthcare channels.
Key Companies
1. ResMed Inc.
A global leader in sleep apnea devices, ResMed continues to innovate in CPAP therapy, cloud-connected patient platforms, and remote monitoring tools. Its AirView system allows real-time patient adherence tracking, improving treatment outcomes.
2. Philips Respironics (a division of Philips Healthcare)
Philips is a major player in diagnostic and therapeutic solutions, offering a range of devices, including BiPAP and CPAP machines. Their DreamStation 2 CPAP platform is one of the most popular in the market.
3. Fisher Paykel Healthcare
Known for its expertise in respiratory and sleep therapy, the company focuses on humidification-based CPAP systems and has a strong global presence, particularly in Asia-Pacific.
4. Idorsia Pharmaceuticals
This Swiss biopharmaceutical company is making waves with its novel orexin receptor antagonists for insomnia treatment, targeting patients who are non-responsive to traditional hypnotics.
5. Merck Co., Inc.
Merck’s entry into the insomnia space with FDA-approved dual orexin receptor antagonists has opened new pathways for treating chronic sleep problems with fewer side effects than conventional therapies.
6. Somnomed
Specializing in oral appliance therapy for sleep apnea, Somnomed offers personalized, non-invasive alternatives to CPAP, especially suitable for mild to moderate OSA (Obstructive Sleep Apnea) patients.
7. Compumedics Limited
An Australia-based sleep diagnostics firm, Compumedics has a strong portfolio in sleep labs, EEG, and home-based sleep testing systems. Its focus on cloud-integrated platforms is reshaping diagnostic accessibility.
Final Outlook
The sleep disorders market is experiencing dynamic changes fueled by consumer health awareness, national policy shifts, and rapid digitalization. The integration of wearable technology, AI, and behavioral health tools has made diagnosis and treatment more accessible, particularly in emerging economies.
As more countries recognize the long-term economic and healthcare burden of untreated sleep disorders, investments in technology, therapy, and education will continue to accelerate. Companies that prioritize patient-centric, data-driven, and affordable solutions are poised to lead the next phase of growth in this high-impact market.
More Trending Reports by Polaris Market Research:
Sacral Nerve Stimulation Market
Central Nervous System Therapeutics Market
Cholesterol Testing Products and Services Market
Clinical Operations and Development Market
Liver Health Supplements Market
Medical Specimen Tracking System Market
Neuroplasticity Enhancement Devices Market
Laparoscopic Retrieval Bag Market
Platinum-Based Cancer Drugs Market
Central Nervous System Therapeutics Market
Cholesterol Testing Products and Services Market
Lower Extremity Implants Market
